{"transactions":[{"id":741680,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:38.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072934","document":"tm2617547-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072934/tm2617547-9_4seq1.xml","form_type":"4"}},{"id":831415,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-23T20:29:59.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":1057,"price":111.75,"value":118119.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":23857.047,"source":{"system":"sec-edgar","filing":"0001090872-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000109087226000036/form4.xml","form_type":"4"}},{"id":831414,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-23T20:29:59.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":2158,"price":111.75,"value":241156.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"148.973 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":22800.047,"source":{"system":"sec-edgar","filing":"0001090872-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000109087226000036/form4.xml","form_type":"4"}},{"id":1122866,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T01:08:12.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056567","document":"tm2517191-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056567/tm2517191-8_4seq1.xml","form_type":"4"}},{"id":1201698,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-18T14:05:08.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":1819,"price":121.18,"value":220426.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"96.204 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":20493.074,"source":{"system":"sec-edgar","filing":"0001127602-25-009725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760225009725/form4.xml","form_type":"4"}},{"id":1246311,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-25T20:44:56.000Z","date":"2025-02-24","kind":"sale","planned":true,"acquired":false,"shares":10056,"price":9.4534,"value":95063.3904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":698239,"source":{"system":"sec-edgar","filing":"0001628280-25-007708","document":"wk-form4_1740516289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007708/wk-form4_1740516289.xml","form_type":"4"}},{"id":1260070,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-20T00:11:52.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":10964,"price":9.8117,"value":107575.4788,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":708295,"source":{"system":"sec-edgar","filing":"0001628280-25-006516","document":"wk-form4_1740010306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025006516/wk-form4_1740010306.xml","form_type":"4"}},{"id":1381942,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-24T20:26:01.000Z","date":"2024-10-23","kind":"other","planned":false,"acquired":false,"shares":598270,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees."}],"balance_after":1151730,"source":{"system":"sec-edgar","filing":"0001628280-24-043632","document":"wk-form4_1729801556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024043632/wk-form4_1729801556.xml","form_type":"4"}},{"id":1381941,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2024-10-24T20:26:01.000Z","date":"2024-10-23","kind":"other","planned":false,"acquired":true,"shares":598270,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by the spouse of the reporting person."}],"balance_after":598270,"source":{"system":"sec-edgar","filing":"0001628280-24-043632","document":"wk-form4_1729801556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024043632/wk-form4_1729801556.xml","form_type":"4"}},{"id":1381940,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-24T20:26:01.000Z","date":"2024-10-23","kind":"other","planned":false,"acquired":false,"shares":598270,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees."}],"balance_after":1151730,"source":{"system":"sec-edgar","filing":"0001628280-24-043632","document":"wk-form4_1729801556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024043632/wk-form4_1729801556.xml","form_type":"4"}},{"id":1381939,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-24T20:26:01.000Z","date":"2024-10-23","kind":"other","planned":false,"acquired":true,"shares":598270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."}],"balance_after":719259,"source":{"system":"sec-edgar","filing":"0001628280-24-043632","document":"wk-form4_1729801556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024043632/wk-form4_1729801556.xml","form_type":"4"}},{"id":1486741,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:21:53.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069666","document":"tm2416702-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069666/tm2416702-8_4seq1.xml","form_type":"4"}},{"id":1495199,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-03T16:17:53.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":10.39,"exercise_date":"2025-05-30","expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001628280-24-026219","document":"wk-form4_1717431464.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024026219/wk-form4_1717431464.xml","form_type":"4"}},{"id":1495198,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T16:17:53.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120989,"source":{"system":"sec-edgar","filing":"0001628280-24-026219","document":"wk-form4_1717431464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024026219/wk-form4_1717431464.xml","form_type":"4"}},{"id":1497062,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-31T14:50:54.000Z","date":"2024-05-29","kind":"gift","planned":false,"acquired":true,"shares":3443,"price":145.48,"value":500887.64,"ownership":{"direct":false,"nature":"George A. Scangos and Leslie S. Wilson Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in the George A. Scangos and Leslie S. Wilson Family Trust."}],"balance_after":17893,"source":{"system":"sec-edgar","filing":"0001127602-24-017078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760224017078/form4.xml","form_type":"4"}},{"id":1497061,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-31T14:50:54.000Z","date":"2024-05-29","kind":"gift","planned":false,"acquired":false,"shares":3443,"price":145.48,"value":500887.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"31.515 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":18577.87,"source":{"system":"sec-edgar","filing":"0001127602-24-017078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760224017078/form4.xml","form_type":"4"}},{"id":1570458,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-19T22:26:27.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":1678,"price":147.48,"value":247471.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer these shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"126.437 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":21989.355,"source":{"system":"sec-edgar","filing":"0001127602-24-010687","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760224010687/form4.xml","form_type":"4"}},{"id":1619561,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-27T00:30:51.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":17722,"price":11.6534,"value":206521.5548,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 20, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.21 to $11.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":112989,"source":{"system":"sec-edgar","filing":"0001628280-24-006980","document":"wk-form4_1708993836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024006980/wk-form4_1708993836.xml","form_type":"4"}},{"id":1619560,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-27T00:30:51.000Z","date":"2024-02-22","kind":"sale","planned":true,"acquired":false,"shares":10028,"price":10.0456,"value":100737.2768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":130711,"source":{"system":"sec-edgar","filing":"0001628280-24-006980","document":"wk-form4_1708993836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024006980/wk-form4_1708993836.xml","form_type":"4"}},{"id":1633835,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-21T02:02:34.000Z","date":"2024-02-20","kind":"sale","planned":true,"acquired":false,"shares":16872,"price":10.2172,"value":172384.5984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 20, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.07 to $10.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":140739,"source":{"system":"sec-edgar","filing":"0001628280-24-005747","document":"wk-form4_1708480944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024005747/wk-form4_1708480944.xml","form_type":"4"}},{"id":1633834,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-21T02:02:34.000Z","date":"2024-02-16","kind":"sale","planned":true,"acquired":false,"shares":10878,"price":10.2396,"value":111386.3688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":157611,"source":{"system":"sec-edgar","filing":"0001628280-24-005747","document":"wk-form4_1708480944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024005747/wk-form4_1708480944.xml","form_type":"4"}},{"id":1758159,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-18T18:14:37.000Z","date":"2023-10-17","kind":"other","planned":false,"acquired":true,"shares":1750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held in the name of  Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees."}],"balance_after":1750000,"source":{"system":"sec-edgar","filing":"0001628280-23-034571","document":"wk-form4_1697652863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828023034571/wk-form4_1697652863.xml","form_type":"4"}},{"id":1758158,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-18T18:14:37.000Z","date":"2023-10-17","kind":"other","planned":false,"acquired":false,"shares":1750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by the spouse of the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-23-034571","document":"wk-form4_1697652863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828023034571/wk-form4_1697652863.xml","form_type":"4"}},{"id":1758157,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-18T18:14:37.000Z","date":"2023-10-17","kind":"other","planned":false,"acquired":true,"shares":1750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees."}],"balance_after":1750000,"source":{"system":"sec-edgar","filing":"0001628280-23-034571","document":"wk-form4_1697652863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828023034571/wk-form4_1697652863.xml","form_type":"4"}},{"id":1758156,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-18T18:14:37.000Z","date":"2023-10-17","kind":"other","planned":false,"acquired":false,"shares":1750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."}],"balance_after":168489,"source":{"system":"sec-edgar","filing":"0001628280-23-034571","document":"wk-form4_1697652863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828023034571/wk-form4_1697652863.xml","form_type":"4"}},{"id":1778948,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T19:54:48.000Z","date":"2023-09-15","kind":"other","planned":false,"acquired":false,"shares":827151,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held in the name of the Katherine Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-049722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123049722/doc4.xml","form_type":"4"}},{"id":1778947,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T19:54:48.000Z","date":"2023-09-15","kind":"other","planned":false,"acquired":false,"shares":111644,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held in the name of the Katherine Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-049722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123049722/doc4.xml","form_type":"4"}},{"id":1778946,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T19:54:48.000Z","date":"2023-09-15","kind":"other","planned":false,"acquired":false,"shares":827151,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in the name of the Jennifer Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-049722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123049722/doc4.xml","form_type":"4"}},{"id":1778945,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T19:54:48.000Z","date":"2023-09-15","kind":"other","planned":false,"acquired":false,"shares":111644,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held in the name of the Jennifer Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-049722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123049722/doc4.xml","form_type":"4"}},{"id":1778944,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T19:54:48.000Z","date":"2023-09-15","kind":"other","planned":false,"acquired":true,"shares":1750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by the spouse of the Reporting Person."}],"balance_after":1750000,"source":{"system":"sec-edgar","filing":"0001209191-23-049722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123049722/doc4.xml","form_type":"4"}},{"id":1778943,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T19:54:48.000Z","date":"2023-09-15","kind":"other","planned":false,"acquired":true,"shares":1750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."}],"balance_after":1918489,"source":{"system":"sec-edgar","filing":"0001209191-23-049722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123049722/doc4.xml","form_type":"4"}},{"id":1778942,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T19:54:48.000Z","date":"2023-09-15","kind":"other","planned":false,"acquired":false,"shares":3500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011."}],"balance_after":33629,"source":{"system":"sec-edgar","filing":"0001209191-23-049722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123049722/doc4.xml","form_type":"4"}},{"id":1863868,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T20:35:08.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":22000,"derivative":{"exercise_price":12.57,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001104659-23-068920","document":"tm2317994-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465923068920/tm2317994-2_4seq1.xml","form_type":"4"}},{"id":1896711,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-11T21:15:06.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. The option vests over four years, with 1/16th of the shares of common stock underlying the option vesting upon the three-month anniversary of the Vesting Commencement Date and an additional 1/16th of the shares of common stock underlying the option vesting at the end of each successive three-month period thereafter, subject to the Reporting Person's continued service as a director."}],"balance_after":44000,"derivative":{"exercise_price":10.76,"expiration_date":"2033-05-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-23-059224","document":"tm2315473-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465923059224/tm2315473-2_4seq1.xml","form_type":"4"}},{"id":1945056,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-21T01:41:28.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":1658,"price":136.82,"value":226847.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"107.055 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":20184.918,"source":{"system":"sec-edgar","filing":"0000899243-23-009227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000089924323009227/doc4.xml","form_type":"4"}},{"id":1993357,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-25T01:34:17.000Z","date":"2023-02-24","kind":"sale","acquired":false,"shares":10880,"price":23.557,"value":256300.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 29, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.215 to $24.01 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":168489,"source":{"system":"sec-edgar","filing":"0001209191-23-013004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123013004/doc4.xml","form_type":"4"}},{"id":1993356,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-25T01:34:17.000Z","date":"2023-02-24","kind":"sale","acquired":false,"shares":4239,"price":22.737,"value":96382.143,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 29, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.195 to $23.160 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":179369,"source":{"system":"sec-edgar","filing":"0001209191-23-013004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123013004/doc4.xml","form_type":"4"}},{"id":1993355,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-25T01:34:17.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":12631,"price":25.973,"value":328064.963,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":183608,"source":{"system":"sec-edgar","filing":"0001209191-23-013004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123013004/doc4.xml","form_type":"4"}},{"id":2003618,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T00:29:20.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":6474,"price":28.8,"value":186451.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 29, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.51 to $29.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":196239,"source":{"system":"sec-edgar","filing":"0001209191-23-011387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011387/doc4.xml","form_type":"4"}},{"id":2003617,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T00:29:20.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":11382,"price":28.015,"value":318866.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 29, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.49 to $28.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":202713,"source":{"system":"sec-edgar","filing":"0001209191-23-011387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011387/doc4.xml","form_type":"4"}},{"id":2003616,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T00:29:20.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":9894,"price":25.288,"value":250199.472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":214095,"source":{"system":"sec-edgar","filing":"0001209191-23-011387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011387/doc4.xml","form_type":"4"}},{"id":2003615,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T00:29:20.000Z","date":"2023-01-18","kind":"other","acquired":true,"shares":64930,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees."}],"balance_after":179930,"source":{"system":"sec-edgar","filing":"0001209191-23-011387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011387/doc4.xml","form_type":"4"}},{"id":2003614,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T00:29:20.000Z","date":"2023-01-18","kind":"other","acquired":false,"shares":64930,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011."}],"balance_after":3533629,"source":{"system":"sec-edgar","filing":"0001209191-23-011387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011387/doc4.xml","form_type":"4"}},{"id":2003613,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T00:29:20.000Z","date":"2022-12-21","kind":"other","acquired":true,"shares":49984,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in the name of the Katherine Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":111644,"source":{"system":"sec-edgar","filing":"0001209191-23-011387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011387/doc4.xml","form_type":"4"}},{"id":2003612,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T00:29:20.000Z","date":"2022-12-21","kind":"other","acquired":false,"shares":49984,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held in the name of the Katherine Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":827151,"source":{"system":"sec-edgar","filing":"0001209191-23-011387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011387/doc4.xml","form_type":"4"}},{"id":2003611,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T00:29:20.000Z","date":"2022-12-21","kind":"other","acquired":true,"shares":49984,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in the name of the Jennifer Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":111644,"source":{"system":"sec-edgar","filing":"0001209191-23-011387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011387/doc4.xml","form_type":"4"}},{"id":2003610,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-22T00:29:20.000Z","date":"2022-12-21","kind":"other","acquired":false,"shares":49984,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for tax planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of the Jennifer Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":827151,"source":{"system":"sec-edgar","filing":"0001209191-23-011387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011387/doc4.xml","form_type":"4"}},{"id":2302600,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-06T21:22:32.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":222000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":222000,"derivative":{"exercise_price":29.48,"expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":222000},"source":{"system":"sec-edgar","filing":"0001209191-22-023524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122023524/doc4.xml","form_type":"4"}},{"id":2302599,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-06T21:22:32.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":223989,"source":{"system":"sec-edgar","filing":"0001209191-22-023524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122023524/doc4.xml","form_type":"4"}},{"id":2323508,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-21T21:12:04.000Z","date":"2022-03-17","kind":"grant","acquired":true,"shares":1785,"price":136.82,"value":244223.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"91.152 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock."}],"balance_after":18419.863,"source":{"system":"sec-edgar","filing":"0001127602-22-010055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760222010055/form4.xml","form_type":"4"}},{"id":2382307,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-22T22:01:53.000Z","date":"2022-02-18","kind":"sale","acquired":false,"shares":17726,"price":30.6501,"value":543303.6726,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":112989,"source":{"system":"sec-edgar","filing":"0001209191-22-011756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122011756/doc4.xml","form_type":"4"}},{"id":2382306,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-22T22:01:53.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":10024,"price":31.9308,"value":320074.3392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":130715,"source":{"system":"sec-edgar","filing":"0001209191-22-011756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122011756/doc4.xml","form_type":"4"}},{"id":2398138,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T21:08:48.000Z","date":"2021-09-07","kind":"gift","acquired":true,"shares":29739,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":140739,"source":{"system":"sec-edgar","filing":"0001209191-22-009231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122009231/doc5.xml","form_type":"5"}},{"id":2398137,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T21:08:48.000Z","date":"2021-09-07","kind":"gift","acquired":true,"shares":877135,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held in the name of the Katherine Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":877135,"source":{"system":"sec-edgar","filing":"0001209191-22-009231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122009231/doc5.xml","form_type":"5"}},{"id":2398136,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T21:08:48.000Z","date":"2021-09-07","kind":"gift","acquired":true,"shares":61660,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in the name of the Katherine Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":61660,"source":{"system":"sec-edgar","filing":"0001209191-22-009231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122009231/doc5.xml","form_type":"5"}},{"id":2398135,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T21:08:48.000Z","date":"2021-09-07","kind":"gift","acquired":true,"shares":877135,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held in the name of the Jennifer Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":877135,"source":{"system":"sec-edgar","filing":"0001209191-22-009231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122009231/doc5.xml","form_type":"5"}},{"id":2398134,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T21:08:48.000Z","date":"2021-09-07","kind":"gift","acquired":true,"shares":61660,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in the name of the Jennifer Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees."}],"balance_after":61660,"source":{"system":"sec-edgar","filing":"0001209191-22-009231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122009231/doc5.xml","form_type":"5"}},{"id":2398133,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T21:08:48.000Z","date":"2021-09-07","kind":"gift","acquired":false,"shares":1907329,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"On August 30, 2018, the reporting person contributed 1,907,329 shares of the Issuer's common stock to the George A. Scangos 2018 Annuity Trust dated August 30, 2018 (the \"Trust\"), a grantor retained annuity trust for the benefit of himself and his children.  Upon termination of the Trust, an aggregate of 1,877,590 of the shares were transferred to trusts for the benefit of each of his daughters, of which he and his spouse serve as trustees.  The remaining 29,739 shares were distributed to the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-009231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122009231/doc5.xml","form_type":"5"}},{"id":2398132,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T21:08:48.000Z","date":"2021-04-01","kind":"gift","acquired":true,"shares":3598559,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011."}],"balance_after":3598559,"source":{"system":"sec-edgar","filing":"0001209191-22-009231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122009231/doc5.xml","form_type":"5"}},{"id":2398131,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T21:08:48.000Z","date":"2021-04-01","kind":"gift","acquired":false,"shares":3598559,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":111000,"source":{"system":"sec-edgar","filing":"0001209191-22-009231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122009231/doc5.xml","form_type":"5"}},{"id":2398130,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-14T21:08:48.000Z","date":"2021-02-16","kind":"gift","acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3709559,"source":{"system":"sec-edgar","filing":"0001209191-22-009231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122009231/doc5.xml","form_type":"5"}},{"id":2776691,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-03-22T19:26:25.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":986,"price":121.593,"value":119890.698,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":16543.711,"source":{"system":"sec-edgar","filing":"0001127602-21-011659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760221011659/form4.xml","form_type":"4"}},{"id":2776690,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-03-22T19:26:25.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":1850,"price":121.593,"value":224947.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer these shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"45.553 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Number of shares reflects transfer of 14,450 shares from direct holdings to the George A. Scangos and Leslie S. Wilson Family Trust."}],"balance_after":15557.711,"source":{"system":"sec-edgar","filing":"0001127602-21-011659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760221011659/form4.xml","form_type":"4"}},{"id":2850434,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T22:01:00.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":222000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the stock option vest and become exercisable on February 16, 2022, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":222000,"derivative":{"exercise_price":67.38,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":222000},"source":{"system":"sec-edgar","filing":"0001209191-21-011916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011916/doc4.xml","form_type":"4"}},{"id":2850433,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-18T22:01:00.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":4609559,"source":{"system":"sec-edgar","filing":"0001209191-21-011916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011916/doc4.xml","form_type":"4"}},{"id":2863482,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-12T22:00:54.000Z","date":"2020-12-28","kind":"gift","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4498559,"source":{"system":"sec-edgar","filing":"0001209191-21-010199","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121010199/doc5.xml","form_type":"5"}},{"id":2863481,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-12T22:00:54.000Z","date":"2020-12-02","kind":"gift","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees."}],"balance_after":115000,"source":{"system":"sec-edgar","filing":"0001209191-21-010199","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121010199/doc5.xml","form_type":"5"}},{"id":2863480,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-12T22:00:54.000Z","date":"2020-12-02","kind":"gift","acquired":false,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4598559,"source":{"system":"sec-edgar","filing":"0001209191-21-010199","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121010199/doc5.xml","form_type":"5"}},{"id":3068237,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-08-05T22:32:35.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":177,"price":93.91,"value":16622.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"47.703 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan."}],"balance_after":28112.158,"source":{"system":"sec-edgar","filing":"0001127602-20-022976","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760220022976/form4.xml","form_type":"4"}},{"id":3141451,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T00:35:38.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":75000,"price":25.96,"value":1947000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.59 to $26.37. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":714717,"source":{"system":"sec-edgar","filing":"0000939767-20-000086","document":"wf-form4_159002131982551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000086/wf-form4_159002131982551.xml","form_type":"4"}},{"id":3147839,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-05-16T00:31:12.000Z","date":"2020-05-15","kind":"exercise","acquired":false,"shares":21686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 21,686 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013."}],"balance_after":0,"derivative":{"exercise_price":5.82,"exercise_date":"2013-12-06","expiration_date":"2020-12-05","underlying":"Common Stock","underlying_shares":21686},"source":{"system":"sec-edgar","filing":"0000939767-20-000084","document":"wf-form4_158958904987782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000084/wf-form4_158958904987782.xml","form_type":"4"}},{"id":3147838,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-05-16T00:31:12.000Z","date":"2020-05-15","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013."}],"balance_after":0,"derivative":{"exercise_price":4.58,"exercise_date":"2013-05-23","expiration_date":"2020-05-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000939767-20-000084","document":"wf-form4_158958904987782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000084/wf-form4_158958904987782.xml","form_type":"4"}},{"id":3147837,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-16T00:31:12.000Z","date":"2020-05-15","kind":"exercise","acquired":true,"shares":21686,"price":5.82,"value":126212.52,"ownership":{"direct":true},"balance_after":789717,"source":{"system":"sec-edgar","filing":"0000939767-20-000084","document":"wf-form4_158958904987782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000084/wf-form4_158958904987782.xml","form_type":"4"}},{"id":3147836,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-16T00:31:12.000Z","date":"2020-05-15","kind":"exercise","acquired":true,"shares":30000,"price":4.58,"value":137400.0,"ownership":{"direct":true},"balance_after":768031,"source":{"system":"sec-edgar","filing":"0000939767-20-000084","document":"wf-form4_158958904987782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000084/wf-form4_158958904987782.xml","form_type":"4"}},{"id":3170537,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-25T00:24:00.000Z","date":"2020-04-24","kind":"sale","acquired":false,"shares":15000,"price":26.24,"value":393600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.86 to $26.66. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4."}],"balance_after":738031,"source":{"system":"sec-edgar","filing":"0000939767-20-000056","document":"wf-form4_158777422299168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000056/wf-form4_158777422299168.xml","form_type":"4"}},{"id":3170536,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-25T00:24:00.000Z","date":"2020-04-23","kind":"sale","acquired":false,"shares":55700,"price":26.23,"value":1461011.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.04 to $26.47. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":753031,"source":{"system":"sec-edgar","filing":"0000939767-20-000056","document":"wf-form4_158777422299168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000056/wf-form4_158777422299168.xml","form_type":"4"}},{"id":3170535,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-25T00:24:00.000Z","date":"2020-04-23","kind":"sale","acquired":false,"shares":44300,"price":25.68,"value":1137624.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.04 to $26.03. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":808731,"source":{"system":"sec-edgar","filing":"0000939767-20-000056","document":"wf-form4_158777422299168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000056/wf-form4_158777422299168.xml","form_type":"4"}},{"id":3172007,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-23T00:50:50.000Z","date":"2020-04-22","kind":"sale","acquired":false,"shares":4200,"price":25.05,"value":105210.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.15. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 6 to this Form 4."}],"balance_after":853031,"source":{"system":"sec-edgar","filing":"0000939767-20-000053","document":"wf-form4_158760303289913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000053/wf-form4_158760303289913.xml","form_type":"4"}},{"id":3172006,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-23T00:50:50.000Z","date":"2020-04-21","kind":"sale","acquired":false,"shares":5800,"price":25.04,"value":145232.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.01 to $25.10. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4."}],"balance_after":857231,"source":{"system":"sec-edgar","filing":"0000939767-20-000053","document":"wf-form4_158760303289913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000053/wf-form4_158760303289913.xml","form_type":"4"}},{"id":3172005,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-23T00:50:50.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":5900,"price":24.7,"value":145730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.59 to $24.88. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4."}],"balance_after":863031,"source":{"system":"sec-edgar","filing":"0000939767-20-000053","document":"wf-form4_158760303289913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000053/wf-form4_158760303289913.xml","form_type":"4"}},{"id":3172004,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-23T00:50:50.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":25600,"price":24.07,"value":616192.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.59 to $24.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":868931,"source":{"system":"sec-edgar","filing":"0000939767-20-000053","document":"wf-form4_158760303289913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000053/wf-form4_158760303289913.xml","form_type":"4"}},{"id":3172003,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-23T00:50:50.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":18500,"price":23.39,"value":432715.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.59 to $23.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":894531,"source":{"system":"sec-edgar","filing":"0000939767-20-000053","document":"wf-form4_158760303289913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000053/wf-form4_158760303289913.xml","form_type":"4"}},{"id":3172648,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-21T23:46:47.000Z","date":"2020-04-17","kind":"grant","acquired":true,"shares":1027,"price":73.009,"value":74980.243,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":27887.455,"source":{"system":"sec-edgar","filing":"0001127602-20-014250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760220014250/form4.xml","form_type":"4"}},{"id":3172647,"issuer":{"id":3062,"kind":"organization","name":"AGILENT TECHNOLOGIES, INC.","symbol":"A"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-21T23:46:47.000Z","date":"2020-04-17","kind":"grant","acquired":true,"shares":3081,"price":73.009,"value":224940.729,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer these shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"80.568 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan."}],"balance_after":26860.455,"source":{"system":"sec-edgar","filing":"0001127602-20-014250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090872/000112760220014250/form4.xml","form_type":"4"}},{"id":3174655,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-18T00:11:32.000Z","date":"2020-04-15","kind":"sale","acquired":false,"shares":25000,"price":18.31,"value":457750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person o November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.11 to $18.56. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":913031,"source":{"system":"sec-edgar","filing":"0000939767-20-000049","document":"wf-form4_158716867487658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000049/wf-form4_158716867487658.xml","form_type":"4"}},{"id":3175504,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-16T21:33:21.000Z","date":"2020-04-14","kind":"other","acquired":true,"shares":236806,"price":29.56,"value":6999985.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a substitution of assets in which 236,806 shares of the Issuer's common stock were transferred to the reporting person from the George A. Scangos 2018 Annuity Trust dated August 30, 2018 (the \"GRAT\") in exchange for other assets.  The reporting person was the beneficial owner of the shares while they were held by the GRAT and remains the beneficial owner of the shares following their withdrawal from the GRAT.  The reporting person believes that the transfer was exempt under Rule 16a-13 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the average of the reported high and low per share prices for the Issuer's common stock on the date of the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The total number of shares of common stock reported herein as directly owned includes 78,087 shares previously reported as indirectly owned through the GRAT and subsequently distributed to the reporting person in accordance with the terms of the GRAT."}],"balance_after":4713559,"source":{"system":"sec-edgar","filing":"0001209191-20-024672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120024672/doc4.xml","form_type":"4"}},{"id":3175503,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-16T21:33:21.000Z","date":"2020-04-14","kind":"other","acquired":false,"shares":236806,"price":29.56,"value":6999985.36,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a substitution of assets in which 236,806 shares of the Issuer's common stock were transferred to the reporting person from the George A. Scangos 2018 Annuity Trust dated August 30, 2018 (the \"GRAT\") in exchange for other assets.  The reporting person was the beneficial owner of the shares while they were held by the GRAT and remains the beneficial owner of the shares following their withdrawal from the GRAT.  The reporting person believes that the transfer was exempt under Rule 16a-13 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the average of the reported high and low per share prices for the Issuer's common stock on the date of the transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in the name of the GRAT, of which the reporting person and his spouse are trustees."}],"balance_after":1907329,"source":{"system":"sec-edgar","filing":"0001209191-20-024672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120024672/doc4.xml","form_type":"4"}},{"id":3179261,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-10T00:20:16.000Z","date":"2020-04-08","kind":"sale","acquired":false,"shares":7065,"price":18.35,"value":129642.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.03 to $18.59. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":938031,"source":{"system":"sec-edgar","filing":"0000939767-20-000048","document":"wf-form4_158647799860062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000048/wf-form4_158647799860062.xml","form_type":"4"}},{"id":3179260,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-10T00:20:16.000Z","date":"2020-04-07","kind":"sale","acquired":false,"shares":16435,"price":18.25,"value":299938.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.56. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":945096,"source":{"system":"sec-edgar","filing":"0000939767-20-000048","document":"wf-form4_158647799860062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000048/wf-form4_158647799860062.xml","form_type":"4"}},{"id":3187527,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-03T00:08:12.000Z","date":"2020-03-31","kind":"sale","acquired":false,"shares":1500,"price":18.06,"value":27090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.14. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":961531,"source":{"system":"sec-edgar","filing":"0000939767-20-000045","document":"wf-form4_158587246981282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000045/wf-form4_158587246981282.xml","form_type":"4"}},{"id":3257541,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-22T01:28:07.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":50000,"price":20.73,"value":1036500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.37 to $21.22. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":963031,"source":{"system":"sec-edgar","filing":"0000939767-20-000028","document":"wf-form4_158233487004494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000028/wf-form4_158233487004494.xml","form_type":"4"}},{"id":3277981,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T01:21:18.000Z","date":"2020-02-12","kind":"sale","acquired":false,"shares":21000,"price":20.02,"value":420420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.08. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":1013031,"source":{"system":"sec-edgar","filing":"0000939767-20-000015","document":"wf-form4_158155686073408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000015/wf-form4_158155686073408.xml","form_type":"4"}},{"id":3277980,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T01:21:18.000Z","date":"2020-02-11","kind":"sale","acquired":false,"shares":4000,"price":20.14,"value":80560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.35. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":1034031,"source":{"system":"sec-edgar","filing":"0000939767-20-000015","document":"wf-form4_158155686073408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000015/wf-form4_158155686073408.xml","form_type":"4"}},{"id":3303342,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-25T01:17:05.000Z","date":"2020-01-22","kind":"sale","acquired":false,"shares":25000,"price":19.75,"value":493750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.67 to $19.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":1038031,"source":{"system":"sec-edgar","filing":"0000939767-20-000011","document":"wf-form4_157991500745631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000011/wf-form4_157991500745631.xml","form_type":"4"}},{"id":3308673,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-18T01:42:41.000Z","date":"2020-01-15","kind":"sale","acquired":false,"shares":25000,"price":20.39,"value":509750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.01 to $20.74. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Adjusted to omit 2,500 shares of Exelixis, Inc. common stock that were mistakenly included in Reporting Person's beneficial ownership reported on prior Form 4 filings."}],"balance_after":1063031,"source":{"system":"sec-edgar","filing":"0000939767-20-000008","document":"wf-form4_157931174373500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000008/wf-form4_157931174373500.xml","form_type":"4"}},{"id":3330652,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-28T01:52:06.000Z","date":"2019-12-27","kind":"sale","acquired":false,"shares":25000,"price":18.25,"value":456250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.07 to $18.85. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":1090531,"source":{"system":"sec-edgar","filing":"0000939767-19-000208","document":"wf-form4_157749790582072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000208/wf-form4_157749790582072.xml","form_type":"4"}},{"id":3330651,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-28T01:52:06.000Z","date":"2019-12-12","kind":"gift","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1115531,"source":{"system":"sec-edgar","filing":"0000939767-19-000208","document":"wf-form4_157749790582072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000208/wf-form4_157749790582072.xml","form_type":"4"}},{"id":3450004,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-03T00:27:39.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":6050,"price":21.23,"value":128441.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.88 to $21.59. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":1128031,"source":{"system":"sec-edgar","filing":"0000939767-19-000158","document":"wf-form4_156479204190426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000158/wf-form4_156479204190426.xml","form_type":"4"}},{"id":3450003,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-03T00:27:39.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":33950,"price":20.48,"value":695296.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.85 to $20.76. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":1134081,"source":{"system":"sec-edgar","filing":"0000939767-19-000158","document":"wf-form4_156479204190426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000158/wf-form4_156479204190426.xml","form_type":"4"}},{"id":3469124,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-04T00:13:09.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":40000,"price":21.58,"value":863200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.40 to $21.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":1168031,"source":{"system":"sec-edgar","filing":"0000939767-19-000146","document":"wf-form4_156219917418366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000146/wf-form4_156219917418366.xml","form_type":"4"}}],"next_cursor":"2019-07-04T00:13:09.000000Z,3469124"}